E. Tarkka

631 total citations
15 papers, 445 citations indexed

About

E. Tarkka is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, E. Tarkka has authored 15 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Epidemiology and 4 papers in Clinical Biochemistry. Recurrent topics in E. Tarkka's work include Viral gastroenteritis research and epidemiology (4 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Clostridium difficile and Clostridium perfringens research (4 papers). E. Tarkka is often cited by papers focused on Viral gastroenteritis research and epidemiology (4 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Clostridium difficile and Clostridium perfringens research (4 papers). E. Tarkka collaborates with scholars based in Finland, United States and Ukraine. E. Tarkka's co-authors include Martti Vaara, A. Siitonen, Päivi Tissari, Elina Mattila, Veli‐Jukka Anttila, Petri S. Mattila, Perttu Arkkila, Helena Ranta, T K Korhonen and Kielo Haahtela and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Bacteriology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

E. Tarkka

15 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Tarkka Finland 11 212 203 102 64 45 15 445
Kwok‐Woon Yu Taiwan 13 274 1.3× 216 1.1× 162 1.6× 128 2.0× 52 1.2× 21 629
F. Espinasse France 9 189 0.9× 207 1.0× 130 1.3× 206 3.2× 42 0.9× 21 463
Reena Raveendran India 11 227 1.1× 243 1.2× 80 0.8× 234 3.7× 42 0.9× 22 560
Tae Yeal Choi South Korea 14 256 1.2× 281 1.4× 85 0.8× 214 3.3× 90 2.0× 29 585
Marina C. Claros Germany 16 153 0.7× 105 0.5× 46 0.5× 89 1.4× 30 0.7× 29 535
R Daniel United Kingdom 12 254 1.2× 261 1.3× 128 1.3× 52 0.8× 33 0.7× 26 619
Gülçin Bayramoğlu Türkiye 13 171 0.8× 227 1.1× 106 1.0× 86 1.3× 10 0.2× 41 459
B. Chattopadhyay United Kingdom 12 132 0.6× 94 0.5× 101 1.0× 52 0.8× 31 0.7× 40 487
H. Darbas France 13 83 0.4× 151 0.7× 105 1.0× 126 2.0× 53 1.2× 34 480
Yeu-Jun Lau Taiwan 10 130 0.6× 145 0.7× 74 0.7× 189 3.0× 73 1.6× 17 395

Countries citing papers authored by E. Tarkka

Since Specialization
Citations

This map shows the geographic impact of E. Tarkka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Tarkka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Tarkka more than expected).

Fields of papers citing papers by E. Tarkka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Tarkka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Tarkka. The network helps show where E. Tarkka may publish in the future.

Co-authorship network of co-authors of E. Tarkka

This figure shows the co-authorship network connecting the top 25 collaborators of E. Tarkka. A scholar is included among the top collaborators of E. Tarkka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Tarkka. E. Tarkka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Rannikko, Antti, Andrew Erickson, Anu Pätäri‐Sampo, et al.. (2016). Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005–2013: a population-based analysis. Prostate Cancer and Prostatic Diseases. 19(4). 417–422. 14 indexed citations
3.
Mattila, Elina, Perttu Arkkila, Petri S. Mattila, et al.. (2013). Extraintestinal Clostridium difficile Infections. Clinical Infectious Diseases. 57(6). e148–e153. 62 indexed citations
4.
Mattila, Elina, Perttu Arkkila, Petri S. Mattila, et al.. (2012). Rifaximin in the treatment of recurrent Clostridium difficile infection. Alimentary Pharmacology & Therapeutics. 37(1). 122–128. 53 indexed citations
5.
Forssten, Sofia D., Elina Kolho, Anneli Lauhio, et al.. (2010). Emergence of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae during the years 2000 and 2004 in Helsinki, Finland. Clinical Microbiology and Infection. 16(8). 1158–1161. 8 indexed citations
6.
Virolainen, Anni, J. Jalava, Salih Ibrahem, et al.. (2010). Comparison of repetitive extragenic palindromic sequence-based PCR with PCR ribotyping and pulsed-field gel electrophoresis in studying the clonality of Clostridium difficile. Clinical Microbiology and Infection. 17(2). 166–175. 18 indexed citations
7.
Antikainen, Jenni, E. Tarkka, Kaisa Haukka, et al.. (2009). New 16-plex PCR method for rapid detection of diarrheagenic Escherichia coli directly from stool samples. European Journal of Clinical Microbiology & Infectious Diseases. 28(8). 899–908. 68 indexed citations
8.
Salmenlinna, Saara, et al.. (2009). Evaluation of a commercial MRSA assay when multiple MRSA strains are causing epidemics. European Journal of Clinical Microbiology & Infectious Diseases. 28(10). 1271–1273. 10 indexed citations
9.
Lyytikäinen, Outi, Silja Mentula, Eija Könönen, et al.. (2007). First isolation of Clostridium difficile PCR ribotype 027 in Finland. Weekly releases (1997–2007). 12(45). E071108.2–E071108.2. 17 indexed citations
10.
Kolho, Elina, Kaisa Huotari, E. Tarkka, & Ville Valtonen. (2003). Incidence and Risk Factors for Nosocomial Infections Caused by Fluoroquinolone-Resistant Escherichia coli. European Journal of Clinical Microbiology & Infectious Diseases. 22(8). 492–495. 20 indexed citations
11.
Salo, Eeva, Harri Saxén, Klaus Hedman, et al.. (2002). Etiological Diagnosis of Childhood Pneumonia by Use of Transthoracic Needle Aspiration and Modern Microbiological Methods. Clinical Infectious Diseases. 34(5). 583–590. 67 indexed citations
12.
Vuopio‐Varkila, Jaana, et al.. (1997). Increase of the number of vancomycin resistant enterococci (VRE) isolated in Helsinki, Finland. Eurosurveillance. 2(12). 97–98. 3 indexed citations
13.
Saxén, Harri, et al.. (1996). Escherichia coli and Appendicitis: Phenotypic Characteristics of E. coli Isolates from Inflamed and Noninflamed Appendices. Clinical Infectious Diseases. 23(5). 1038–1042. 11 indexed citations
14.
Tarkka, E., H. Åhman, & A. Siitonen. (1994). Ribotyping as an epidemiologic tool forEscherichia coli. Epidemiology and Infection. 112(2). 263–274. 28 indexed citations
15.
Korhonen, T K, E. Tarkka, Helena Ranta, & Kielo Haahtela. (1983). Type 3 fimbriae of Klebsiella sp.: molecular characterization and role in bacterial adhesion to plant roots. Journal of Bacteriology. 155(2). 860–865. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026